Prehospital Thrombolysis in Acute Myocardial Infarction

Thrombosis Research

Volumn 103, Issue SUPPL. 1, 2001, Pages

  Arntz, Hans Richard ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Acute myocardial infarction; Out of hospital care; Thrombolysis

Indexed keywords

FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT;

ACUTE HEART INFARCTION; ARTICLE; BLEEDING; BLOOD CLOT LYSIS; CHRONOTHERAPY; CLINICAL FEATURE; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; EMERGENCY HEALTH SERVICE; FIBRINOLYTIC THERAPY; HEART MUSCLE REPERFUSION; HOSPITALIZATION; HUMAN; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; TRANSLUMINAL CORONARY ANGIOPLASTY;

EMERGENCY MEDICAL SERVICES; HUMANS; MYOCARDIAL INFARCTION; THROMBOLYTIC THERAPY; TIME FACTORS;

EID: 0035975590     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(01)00303-6     Document Type: Article

References (42)

1. Early thrombolytic treatment in acute myocardial infarction: Reappraisal of the golden hour
2. Indications for fibrinolytic therapy in suspected acute myocardial infarction: Collaborative overview of early mortality and major morbidity results from all randomized trials of more than 1000 patients
3. The wavefront phenomenon of ischemic cell death: I. Myocardial infarct size vs duration of coronary occlusion in dogs
4. Intravenous short-term infusion of streptokinase in acute myocardial infarction
5. The pre-hospital management of acute heart attacks
6. Prehospital thrombolytic therapy with either alteplase or streptokinase. Practical applications, complications and long-term results in 529 patients
7. Myocardial infarction triage and intervention project-phase I: Patient characteristics and feasibility of prehospital initiation of thrombolytic therapy
8. Prehospital-initiated vs hospital-initiated thrombolytic therapy. The MITI trial
9. Prehospital recognition of AMI using independent nurse/paramedic 12-lead ECG evaluation: Impact on in-hospital times to thrombolysis in a rural community hospital
10. Feasibility, safety, and efficacy of domiciliary thrombolysis by general practitioners: Grampian Region Early Anistreplase Trial
11. Prevention of myocardial damage in acute myocardial ischemia by early treatment with intravenous streptokinase
12. Should thrombolytic therapy be administrated in the mobile intensive care unit in patients with evolving myocardial infarction? A pilot study
13. Early intravenous thrombolysis in acute myocardial infarction: The Jerusalem experience
14. Prehospital thrombolysis in acute myocardial infarction
15. Improved survival but not left ventricular function with early and prehospital treatment with plasminogen activator in acute myocardial infarction
16. Prehospital thrombolysis in acute myocardial infarction: The Belgian Eminase Prehospital Study (BEPS)
17. Efficiency of a physician-operated mobile intensive care unit for prehospital thrombolysis in acute myocardial infarction
18. Prehospital use of APSAC: Results of a placebo-controlled study
19. Prehospital thrombolysis: Beneficial effects of very early treatment on infarct size and left ventricular function
20. Logistical problems in prehospital thrombolysis
21. Accuracy of computer-interpreted electrocardiography in selecting patients for thrombolytic therapy
22. Ist die prästationäre Thrombolyse bei akutem Myokardinfarkt als Routinemaßnahme sinnvoll?
23. Meta-analysis of randomised trials of prehospital versus hospital thrombolysis
24. Prehospital thrombolytic therapy in patients with suspected acute myocardial infarction
25. Mortality and prehospital thrombolysis for acute myocardial infarction: A meta-analysis
26. Halving of mortality at 1 year by domiciliary thrombolysis in the Grampian Region Early Anistreplase Trial (GREAT)
27. Quantification of the benefit of earlier thrombolytic therapy: Five-year results of the Grampian Region Early Anistreplase Trial (GREAT)
28. Influence of early prehospital thrombolysis on mortality and event-free survival (The Myocardial Infarction Triage and Intervention (MITI) randomized trial)
29. Relation between symptom duration before thrombolytic therapy and final myocardial infarct size
30. Illusion of reperfusion
31. Prehospital intravenous streptokinase evolving myocardial infarction: A randomized study about feasibility, safety, and time gain
32. Time delays in provision of thrombolytic treatment in six district hospitals
33. Time delays in the diagnosis and treatment of acute myocardial infarction: A tale of eight cities: Report from the Pre-hospital Study Group and the Cincinnati Heart Project
34. Pre-hospital and hospital time delays in thrombolytic treatment in patients with suspected acute myocardial infarction. Analysis of data from the EMIP study
35. Reduction in hospital time to thrombolytic therapy by audit of policy guidelines
36. Epidemiology of avoidable delay in the care of patients with acute myocardial infarction in Italy. A GISSI-generated study
37. A prospective trial of intravenous streptokinase in acute myocardial infarction (ISAM). Mortality, morbidity, and infarct size at 21 days
38. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17187 cases of suspected acute myocardial infarction: ISIS-2
39. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction
40. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review
41. A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction the PACT trial. PACT investigators. Plasminogen-activator Angioplasty Compatibility Trial
42. A matched comparison of the combination of prehospital thrombolysis and standby rescue angioplasty with primary angioplasty